Innovative Medical (China) Performance
| 002173 Stock | 8.71 0.02 0.23% |
On a scale of 0 to 100, Innovative Medical holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Innovative Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innovative Medical is expected to be smaller as well. Please check Innovative Medical's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to make a quick decision on whether Innovative Medical's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 20:10 | Ex Dividend Date 2018-06-25 | Last Split Date 2011-05-06 |
1 | Chinas Innovative Medical Gains on Plan to Buy Stake in AI Medical Management Startup - Yicai Global | 08/29/2024 |
2 | ICU Medical to Present at UBS Global Healthcare Conference in November 2024 ICUI Stock News - StockTitan | 11/06/2024 |
| Begin Period Cash Flow | 658.3 M |
Innovative |
Innovative Medical Relative Risk vs. Return Landscape
If you would invest 618.00 in Innovative Medical Management on August 31, 2024 and sell it today you would earn a total of 253.00 from holding Innovative Medical Management or generate 40.94% return on investment over 90 days. Innovative Medical Management is generating 0.6942% of daily returns and assumes 4.28% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than Innovative, and 87% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Innovative Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innovative Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Innovative Medical Management, and traders can use it to determine the average amount a Innovative Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1622
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 002173 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.28 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Innovative Medical is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innovative Medical by adding it to a well-diversified portfolio.
Innovative Medical Fundamentals Growth
Innovative Stock prices reflect investors' perceptions of the future prospects and financial health of Innovative Medical, and Innovative Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innovative Stock performance.
| Return On Equity | -0.0256 | ||||
| Return On Asset | -0.0147 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 3.36 B | ||||
| Shares Outstanding | 441.28 M | ||||
| Price To Book | 2.09 X | ||||
| Price To Sales | 4.86 X | ||||
| Revenue | 805.59 M | ||||
| Gross Profit | 46.16 M | ||||
| EBITDA | 33.94 M | ||||
| Net Income | (34.29 M) | ||||
| Total Debt | 30.17 M | ||||
| Book Value Per Share | 4.17 X | ||||
| Cash Flow From Operations | 11.03 M | ||||
| Earnings Per Share | (0.11) X | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | (1.3 B) | ||||
About Innovative Medical Performance
By analyzing Innovative Medical's fundamental ratios, stakeholders can gain valuable insights into Innovative Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Innovative Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innovative Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Innovative Medical is entity of China. It is traded as Stock on SHE exchange.Things to note about Innovative Medical performance evaluation
Checking the ongoing alerts about Innovative Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innovative Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Innovative Medical appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 805.59 M. Net Loss for the year was (34.29 M) with profit before overhead, payroll, taxes, and interest of 46.16 M. | |
| About 42.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: ICU Medical to Present at UBS Global Healthcare Conference in November 2024 ICUI Stock News - StockTitan |
- Analyzing Innovative Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innovative Medical's stock is overvalued or undervalued compared to its peers.
- Examining Innovative Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Innovative Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innovative Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Innovative Medical's stock. These opinions can provide insight into Innovative Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Innovative Stock analysis
When running Innovative Medical's price analysis, check to measure Innovative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medical is operating at the current time. Most of Innovative Medical's value examination focuses on studying past and present price action to predict the probability of Innovative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovative Medical's price. Additionally, you may evaluate how the addition of Innovative Medical to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance |